Biomarkers Consortium
-
Biomarkers Consortium of the FNIH selects ICON to support study evaluating variability in insulin secretory parameters
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced it has received a contract award from the Foundation for the National Institutes of Health (FNIH) to provide clinical support for the Biomarkers Consortium study entitled Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects.
Biomarkers Consortium | 31 October 2011
